PHARMACEUTICAL RAW MATERIALS AND EXCIPIENTS NO FURTHER A MYSTERY

“The present circumstance has exposed some structural weaknesses within the EU’s medicines supply chain in addition to a significant dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides claimed. She advised that supply chain issues be tackled in an EU pharmaceutical method anticipated to generally be launched by the